The existing Wurster chamber has been modified and a new and innovative swirl type of air and particles inside of insert has been achieved.
F.14 Improvements to existing production methods and tools or processes
COBISS.SI-ID: 2807665In the present invention novel prolonged release pharmaceutical composition is described comprising quetiapine and carrageenan.
F.21 Development of new health/diagnostic methods/procedures
COBISS.SI-ID: 2957937ZIMMER, Andreas, MRHAR, Aleš, KHINAST, Andreas, ROBLEGG, Eva. [Introduction]. V: 8th Central European Symposium on Pharmaceutical Technology (CESPT), Satellite Symposium: 4th International Graz Congress on Pharmaceutical Engineering, September 16th-18th, Graz, Austria. Abstracts of the 8th Central European Symposium on Pharmaceutical Technology (CESPT), Satellite Symposium: 4th International Graz Congress on Pharmaceutical Engineering, September 16th-18th, Graz, Austria
B.01 Organiser of a scientific meeting
COBISS.SI-ID: 2991217This invention relates to the pharmaceutical dosage forms which enable a controlled and/or a targeted delivery of an active substance to the selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (designated as LK 423). Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed.
F.32 International patent
COBISS.SI-ID: 1812337A psychometrically valid, multidimensional, self-administered, general questionnaire measuring patient satisfaction with pharmacy performance for outpatients was developed. The questionnaire focuses on issues expressed as important by patients, takes into account services as well as the supporting structure and includes items relevant to an individual pharmacy.
F.22 Improvement to existing health/diagnostic methods/procedures
COBISS.SI-ID: 2806129